Physical Activity Program for TRD
Remotely Delivered Physical Activity Program for Treatment-Resistant Depression: A Pilot Randomized Controlled Trial
1 other identifier
interventional
30
1 country
1
Brief Summary
This is a pilot study examining the delivery of a remotely delivered, one-on-one, individualized physical activity (PA) program in adult participants with treatment-resistant depression (TRD).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 29, 2024
CompletedFirst Posted
Study publicly available on registry
May 8, 2024
CompletedStudy Start
First participant enrolled
September 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedApril 30, 2025
April 1, 2025
1.2 years
April 29, 2024
April 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Feasibility
Recruitment rate, withdrawal rate, adherence rate, and data completion rate
13 weeks
Acceptability
Responses to an exit survey
13 weeks
Acceptability
Responses to semi-structured qualitative interviews
13 weeks
Secondary Outcomes (4)
Hamilton Depression Rating Scale-17
13 weeks
Patient Health Questionnaire-9
13 weeks
General Anxiety Disorder-7
13 weeks
World Health Organization - Five Well-Being Index
13 weeks
Other Outcomes (3)
Total duration of sleep; awake, light, rapid eye movement, and deep sleep durations
13 weeks
Metabolic equivalent minutes
13 weeks
Readiness (interpreted from sleep, activity, resting heart rate, heart rate variability, recovery index, and body temperature scores)
13 weeks
Study Arms (2)
PA program
EXPERIMENTALParticipants in the PA group will receive a 4-week remotely delivered one-on-one individualized PA program adjunct to TAU.
TAU
NO INTERVENTIONParticipants in the TAU group will be given a handout with the Canadian 24-hour movement guidelines and be told that they are encouraged to engage in PA.
Interventions
Participants will meet with their program trainer once a week virtually for 4 weeks to engage in 30 minutes of behavioral change coaching and 30 minutes of a structured PA program that is tailored to their needs and goals. The intensity of the PA sessions will be self-selected. PA sessions will involve a warmup, a conditioning component consisting of individualized aerobic or resistance exercises, and a cool down/stretch. Participants will also be instructed to independently engage in PA (outside of their session with the trainer) for 120 minutes at 50-65% of their maximum work capacity. This can be done by engaging in PA between 3-5 times per week.
Eligibility Criteria
You may qualify if:
- Sedentary adults (engage in less than 60 minutes of moderate-to-vigorous PA per week) between the ages of 18 and 65 years, inclusive, capable of giving informed consent.
- Participants meeting diagnostic criteria for major depressive disorder without psychotic symptoms according to the Diagnostic and Statistical Manual of Mental Disorders - 5th Ed. and currently experiencing a major depressive episode (MDE) as confirmed by the Mini International Neuropsychiatric Interview (MINI).
- A Montgomery-Åsberg Depression Rating Scale total score of ≥ 7 at screening (mild-to-severe MDE).
- Failure of at least two trials of antidepressant therapy of adequate dose and duration during the current episode as established by the Antidepressant Treatment History Form and self-report.
- Receiving treatments congruent with Canadian Network for Mood and Anxiety Treatments guidelines with no changes to treatments one month before screening (28 days).
You may not qualify if:
- Current symptoms of mania, hypomania, mixed episodes, or psychosis.
- Have received a diagnosis of alcohol or a substance use disorder within the past 3 months or as confirmed by the MINI. Other secondary psychiatric comorbidities (e.g., anxiety disorders, trauma-related disorders, etc.) will not be excluded.
- Pregnant females.
- Acute risk for a cardiovascular event (i.e., cardiovascular event in the past within the past 12 months).
- Have any medical contraindications to exercise according to the Physical Activity Readiness Questionnaire.
- Self-reported balance, gait, or locomotion difficulties that would preclude participation in a PA program.
- Have any other condition that, in the opinion of the investigator(s), would adversely affect the subject's ability to complete the study or its measures.
- Have exercise-induced asthma.
- Taking medication that interferes with heart rate response to exercise, such as beta blockers.
- Do not own a smartphone.
- Do not have reliable access to the Internet.
- Have previously received intravenous ketamine treatment in the last 2 months.
- Non-English-speaking individuals are excluded because the ability to communicate study information, answer questions accurately and completely about the study, and obtain consent are necessary.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Unity Health Torontolead
- University of Torontocollaborator
Study Sites (1)
St. Michael's Hospital, Unity Health Toronto
Toronto, Ontario, Canada
Related Publications (1)
Tassone VK, Quesnel DA, Parkington K, Rueda A, Martin J, Lee GH, Teixeira A, deJonge ML, Lou W, Wiljer D, Mulsant BH, Sabiston CM, Bhat V. Improving adherence to physical activity in treatment-resistant depression: Protocol for a pilot randomized controlled trial of a remotely delivered program. PLoS One. 2025 Sep 2;20(9):e0330848. doi: 10.1371/journal.pone.0330848. eCollection 2025.
PMID: 40892783DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 29, 2024
First Posted
May 8, 2024
Study Start
September 19, 2024
Primary Completion
December 1, 2025
Study Completion
December 1, 2025
Last Updated
April 30, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share